查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2004544

GMP蛋白质市场报告：趋势、预测和竞争分析（至2035年）

GMP Protein Market Report: Trends, Forecast and Competitive Analysis to 2035
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

受包括生物製药市场在内的多个市场机会的推动，全球GMP蛋白市场前景光明。预计2026年至2035年，全球GMP蛋白市场将以6.4%的复合年增长率成长，到2035年市场规模预计将达到75亿美元。该市场的主要成长要素包括生物製药生产需求的成长、对高品质蛋白疗法的需求不断增加以及对先进药物研发的日益重视。

  • 根据 Lucintel 的预测，按产品类型划分，细胞激素预计在整个预测期内仍将是最大的细分市场。
  • 按应用领域划分，生物製药预计仍将是最大的细分市场。
  • 按地区划分，预计亚太地区在预测期内将呈现最高的成长率。

GMP蛋白市场的新趋势

在技​​术进步、对高品质蛋白质需求不断增长以及消费者对健康和永续性的偏好转变的推动下，GMP蛋白质市场正在快速发展。随着製药、营养保健品、食品饮料等行业寻求可靠且符合规范的蛋白质来源，市场参与者正积极创新以满足这些需求。这些新趋势正在重塑竞争格局，并影响产品开发、监管标准和供应链动态。对于希望掌握成长机会并克服这一动态市场环境中挑战的利害关係人相关人员，了解这些关键趋势至关重要。

  • 植物来源蛋白需求日益增长：受健康、环境和伦理因素的驱动，消费者对植物来源蛋白产品的需求日益增长。这一趋势正在推动植物来源GMP蛋白的创新，拓展产品系列，并促使生产商开发符合严格GMP标准的、永续的、无过敏原的、功能性的蛋白质原料。这种转变正在推动更广泛的洁净标示和纯素产品转型，从而影响市场成长和多元化。
  • 蛋白质生产领域的技术创新：发酵、重组DNA技术和精准生物生物製程的进步正在提高GMP蛋白质生产的效率、纯度和可扩展性。这些创新使得生产具有高生物活性和高一致性的复杂蛋白质成为可能，从而降低成本并更好地符合机能性食品标准。这一趋势正在加速新产品的开发，并拓展其在製药和营养保健品领域的应用。
  • 更严格的监管和更高的品质标准：各国政府和产业组织正在实施更严格的GMP法规，以确保产品的安全性、有效性和可追溯性。这一趋势要求製造商采取严格的品管措施，投资先进的检测技术，并保持透明的供应链。加强法律规范提高了消费者信心，并为符合GMP规范的高品质蛋白质产品在全球市场创造了机会。
  • 个人化营养和治疗领域应用日益广泛：随着对客製化营养方案和标靶治疗的需求不断增长，符合GMP标准的蛋白质在个人化医疗中的应用也日益普及。这一趋势涉及针对特定健康状况、年龄层或基因特征开发专用蛋白质配方，而这需要高品质、符合GMP标准的原材料。这正在改变产品开发策略，并将市场范围扩展到临床和健康领域。
  • 致力于永续性和道德采购：市场相关人员正优先考虑环保实践，例如减少碳足迹、利用可再生资源以及确保原材料的道德采购。这些实践符合消费者价值观和监管要求，并对产品标籤、行销和供应链管理产生影响。强调永续性有助于提升品牌声誉，并在竞争激烈的GMP蛋白市场中脱颖而出。

总而言之，这些趋势正在重塑整个GMP蛋白市场，它们促进创新、提升品质和安全标准，并使产品与消费者价值观相契合。这些趋势正在拓展健康、保健和治疗领域的市场机会，同时鼓励永续实践。在技​​术进步和不断变化的消费者需求的驱动下，该市场有望迎来显着成长。

GMP蛋白市场近期趋势

受製药、营养保健品和食品业对高品质、符合监管标准的蛋白质来源需求不断增长的推动，GMP蛋白质市场正经历快速成长。生物技术工艺的进步和日益严格的监管标准正在重塑市场动态。生产技术的创新和应用领域的拓展为相关人员创造了新的机会。消费者健康意识的增强和监管合规性的提高，为这一不断变化的市场格局带来了巨大的扩张潜力。各公司正大力投资研发，以满足不断变化的标准和消费者偏好，蓄势待发，力求在持续成长中蓬勃发展。

  • 医药蛋白需求不断增长：医药研发和生产过程中对符合GMP规范的蛋白的需求日益增长，市场机会也随之扩大。製药公司将品质和安全放在首位，这推动了对GMP认证蛋白的需求。这一趋势最终将透过提高产品可靠性、降低污染风险和确保符合监管要求，从而改善患者的治疗效果。生产流程优化技术的进步使得GMP蛋白更容易取得且价格更实惠，从而惠及市场。随着医疗保健需求的持续增长，预计这一领域将继续扩大，吸引投资并促进创新。
  • 营养保健品和机能性食品产业的扩张：消费者对健康和保健日益增长的兴趣推动了营养保健品和机能性食品中对符合GMP标准的蛋白质的需求。这些产品需要高品质、安全有效的成分，因此GMP认证至关重要。市场正在加大研发投入，以开发符合监管标准的新型蛋白质配方。这种成长将提升产品信誉和消费者信心，从而促进产品的更广泛应用。在健康意识增强的消费者行为的推动下，将GMP蛋白质添加到日常食品和膳食补充剂中预计将对市场成长产生重大影响。
  • 生产过程的技术创新：重组DNA技术和发酵等生物技术进步正在提高GMP蛋白的生产效率。这些创新带来了成本降低、产量提高和产品均一性增强。纯化和稳定化技术的改进进一步提升了蛋白质品质。这些技术进步使製造商能够在满足严格监管标准的同时扩展产品线。自动化和製程优化的日益普及有望加速市场成长，并使GMP蛋白在各行业更容易获得。
  • 加强监管和品质标准：全球日益严格的法规结构强调GMP蛋白生产的品质、安全性和可追溯性。符合这些标准对于市场准入和业务拓展至关重要。监管机构正在更新指南，并要求企业投资于品质保证和管理系统。这种对标准的重视增强了消费者信心，并促进了国际贸易。不断变化的监管环境正在推动品管领域的创新，并透过确保GMP蛋白符合最高的安全性和有效性标准，促进市场稳定和成长。
  • 投资与策略联盟的拓展：製药、生技和食品公司正加大投资，致力于开发符合GMP标准的蛋白质产品。战略联盟和伙伴关係正在加速技术转移和研发进程。这些联盟使企业能够进入新市场、共用专业知识并加速产品开发。投资的涌入也为基础设施升级和创新工作提供了支持。这一趋势增强了市场竞争力，提高了市场韧性，确保了高品质GMP蛋白质的稳定供应。总而言之，增加资金筹措和加强联盟合作对于推动市场永续成长和技术进步至关重要。

GMP蛋白市场近期的发展正透过提升产品品质、拓展应用领域和加强监管合规性，对产业产生重大影响。这些因素共同推动创新，增强市场竞争力，并满足日益增长的全球需求。在不断变化的技术和监管环境下，市场预计将持续成长，吸引投资并促进新的合作关係。这种充满活力的环境将惠及消费者、製造商和监管机构，最终巩固全球GMP蛋白产业，并推动医疗保健和营养领域的进步。

目录

第一章执行摘要

第二章 市场概览

  • 背景与分类
  • 供应链

第三章 市场趋势与预测分析

  • 宏观经济趋势与预测
  • 产业驱动因素与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

第四章 全球GMP蛋白质市场：按类型划分

  • 吸引力分析：按类型
  • 细胞激素
  • 其他的

第五章 全球GMP蛋白质市场：按应用划分

  • 吸引力分析：依目的
  • 生物製药
  • 其他的

第六章 区域分析

第七章：北美GMP蛋白市场

  • 北美GMP蛋白市场：按类型划分
  • 北美GMP蛋白质市场：按应用领域划分
  • 美国GMP蛋白质市场
  • 加拿大GMP蛋白质市场
  • 墨西哥的GMP蛋白质市场

第八章：欧洲GMP蛋白质市场

  • 欧洲GMP蛋白质市场：按类型划分
  • 欧洲GMP蛋白质市场：按应用领域划分
  • 德国GMP蛋白市场
  • 法国GMP蛋白市场
  • 义大利GMP蛋白市场
  • 西班牙GMP蛋白市场
  • 英国GMP蛋白市场

第九章：亚太地区GMP蛋白质市场

  • 亚太地区GMP蛋白市场：依类型划分
  • 亚太地区GMP蛋白市场：依应用领域划分
  • 中国GMP蛋白市场
  • 印度GMP蛋白市场
  • 日本GMP蛋白质市场
  • 韩国GMP蛋白市场
  • 印尼GMP蛋白市场

第十章：世界其他地区的GMP蛋白质市场

  • 其他地区的GMP蛋白市场：按类型划分
  • 其他地区的GMP蛋白市场：依应用领域划分
  • 中东GMP蛋白市场
  • 南非GMP蛋白质市场
  • 非洲GMP蛋白市场

第十一章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析
  • 市占率分析

第十二章 机会与策略分析

  • 价值链分析
  • 成长机会分析
  • 新趋势：全球GMP蛋白质市场
  • 战略分析

第十三章：价值链中主要企业的公司概况

  • 竞争分析概述
  • R&D Systems
  • PeproTech
  • GenScript
  • Waisman Biomanufacturing
  • Thermo Fisher Scientific
  • RayBiotech
  • Sino Biological
  • Leadgene Biomedical
  • Bio-Techne
  • ACROBiosystems

第十四章附录

The future of the global GMP protein market looks promising with opportunities in the biopharmaceutical and other markets. The global GMP protein market is expected to reach an estimated $7.5 billion by 2035 with a CAGR of 6.4% from 2026 to 2035. The major drivers for this market are the increasing demand for biopharmaceutical production, the rising need for high-quality protein therapeutics, and the growing focus on advanced drug development.

  • Lucintel forecasts that, within the type category, cytokine will remain the largest segment over the forecast period.
  • Within the application category, biopharmaceutical will remain the largest segment.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the GMP Protein Market

The GMP protein market is experiencing rapid evolution driven by technological advancements, increasing demand for high-quality proteins, and shifting consumer preferences towards health and sustainability. As industries such as pharmaceuticals, nutraceuticals, and food & beverages seek reliable and compliant protein sources, market players are innovating to meet these needs. Emerging trends are shaping the competitive landscape, influencing product development, regulatory standards, and supply chain dynamics. Understanding these key trends is essential for stakeholders aiming to capitalize on growth opportunities and navigate challenges in this dynamic market environment.

  • Growing Demand for Plant-Based Proteins: Consumers are increasingly seeking plant-derived protein options due to health, environmental, and ethical considerations. This trend is driving innovation in plant-based GMP proteins, expanding product portfolios, and encouraging manufacturers to develop sustainable, allergen-free, and functional protein ingredients that meet strict GMP standards. The shift supports a broader move towards clean-label and vegan products, influencing market growth and diversification.
  • Technological Innovations in Protein Production: Advances such as fermentation, recombinant DNA technology, and precision bioprocessing are enhancing the efficiency, purity, and scalability of GMP protein manufacturing. These innovations enable the production of complex proteins with high bioactivity and consistency, reducing costs and improving compliance with regulatory standards. This trend is fostering new product development and expanding applications across pharmaceuticals and nutraceuticals.
  • Increasing Regulatory Stringency and Quality Standards: Governments and industry bodies are implementing stricter GMP regulations to ensure product safety, efficacy, and traceability. This trend compels manufacturers to adopt rigorous quality control measures, invest in advanced testing, and maintain transparent supply chains. Enhanced regulatory oversight boosts consumer confidence and opens opportunities for premium, compliant GMP protein products in global markets.
  • Rising Adoption in Personalized Nutrition and Therapeutics: The demand for tailored nutritional solutions and targeted therapies is fueling the use of GMP proteins in personalized medicine. This trend involves developing specialized protein formulations for specific health conditions, age groups, or genetic profiles, requiring high-quality, GMP-compliant ingredients. It is transforming product development strategies and expanding the market scope into clinical and wellness sectors.
  • Sustainability and Ethical Sourcing Initiatives: Market players are prioritizing environmentally friendly practices, such as reducing carbon footprints, utilizing renewable resources, and ensuring ethical sourcing of raw materials. These initiatives align with consumer values and regulatory expectations, influencing product labeling, marketing, and supply chain management. Emphasizing sustainability enhances brand reputation and drives market differentiation in the competitive GMP protein landscape.

In summary, these trends are collectively reshaping the GMP protein market by fostering innovation, enhancing quality and safety standards, and aligning products with consumer values. They are expanding market opportunities across health, wellness, and therapeutic sectors while encouraging sustainable practices. As these developments continue, the market is poised for significant growth, driven by technological progress and evolving consumer demands.

Recent Developments in the GMP Protein Market

The GMP protein market is experiencing rapid growth driven by increasing demand for high-quality, compliant protein sources across pharmaceuticals, nutraceuticals, and food industries. Advances in biotechnological processes and stricter regulatory standards are shaping market dynamics. Innovations in production techniques and expanding applications are creating new opportunities for stakeholders. This evolving landscape offers significant potential for market expansion, driven by consumer health awareness and regulatory compliance. Companies are investing heavily in R&D to meet evolving standards and consumer preferences, positioning the market for sustained growth.

  • Growing Demand for Pharmaceutical Proteins: The increasing need for GMP-compliant proteins in drug development and manufacturing is expanding market opportunities. Pharmaceutical companies prioritize quality and safety, driving demand for GMP-certified proteins. This trend enhances product reliability, reduces contamination risks, and ensures regulatory compliance, ultimately improving patient outcomes. The market benefits from technological advancements that streamline production processes, making GMP proteins more accessible and affordable. As healthcare needs grow, this segment is expected to see continued expansion, attracting investments and fostering innovation.
  • Expansion in Nutraceutical and Functional Food Sectors: The rising consumer focus on health and wellness is boosting demand for GMP proteins in nutraceuticals and functional foods. These products require high-quality, safe, and effective ingredients, making GMP certification essential. The market is witnessing increased R&D to develop novel protein formulations that meet regulatory standards. This growth enhances product credibility and consumer trust, leading to wider adoption. The integration of GMP proteins into everyday foods and supplements is expected to significantly influence market growth, driven by health-conscious consumer behavior.
  • Technological Innovations in Production Processes: Advances in biotechnological methods, such as recombinant DNA technology and fermentation, are improving GMP protein production efficiency. These innovations reduce costs, increase yields, and ensure product consistency. Enhanced purification and stabilization techniques further improve protein quality. These technological developments enable manufacturers to meet stringent regulatory standards while expanding product portfolios. The increased adoption of automation and process optimization is expected to accelerate market growth, making GMP proteins more accessible across various industries.
  • Regulatory and Quality Standards Enhancements: Stricter global regulatory frameworks are emphasizing quality, safety, and traceability in GMP protein manufacturing. Compliance with these standards is crucial for market entry and expansion. Regulatory bodies are updating guidelines, prompting companies to invest in quality assurance and control systems. This focus on standards boosts consumer confidence and facilitates international trade. The evolving regulatory landscape encourages innovation in quality management, ensuring that GMP proteins meet the highest safety and efficacy benchmarks, thereby fostering market stability and growth.
  • Increasing Investment and Strategic Collaborations: The market is witnessing heightened investments from pharmaceutical, biotech, and food companies aiming to develop GMP-compliant proteins. Strategic collaborations and partnerships are facilitating technology transfer, research, and development. These alliances help companies access new markets and share expertise, accelerating product development. Investment influx supports infrastructure upgrades and innovation initiatives. This trend enhances competitive positioning and market resilience, ensuring a steady supply of high-quality GMP proteins. Overall, increased funding and collaborations are pivotal in driving sustained market growth and technological advancement.

The GMP protein markets recent developments are significantly impacting the industry by enhancing product quality, expanding application areas, and ensuring regulatory compliance. These factors collectively foster innovation, improve market competitiveness, and meet rising global demand. As technological and regulatory landscapes evolve, the market is poised for continued growth, attracting investments and fostering new collaborations. This dynamic environment benefits consumers, manufacturers, and regulators, ultimately strengthening the global GMP protein industry and supporting healthcare and nutrition advancements.

Strategic Growth Opportunities in the GMP Protein Market

The GMP protein market is experiencing rapid expansion driven by increasing demand for high-quality, safe, and effective protein products across pharmaceuticals, nutraceuticals, and food industries. Advances in biotechnological processes, regulatory support, and rising consumer awareness about health benefits are fueling growth. Companies are investing in innovative manufacturing techniques to meet stringent quality standards. This evolving landscape presents numerous strategic opportunities for market players to capitalize on emerging applications, enhance product portfolios, and strengthen global presence.

  • Growing Demand for Pharmaceutical-grade Proteins: The increasing need for high-purity, GMP-compliant proteins in drug development, biologics, and biosimilars is a significant growth driver. Regulatory agencies emphasize quality and safety, prompting manufacturers to adopt GMP standards. This demand is further fueled by advancements in personalized medicine and biologic therapies, creating opportunities for companies to expand their GMP protein manufacturing capabilities and cater to pharmaceutical clients seeking reliable, compliant products.
  • Expansion of Nutraceutical and Functional Food Markets: Rising consumer awareness about health and wellness is boosting demand for GMP-certified proteins in dietary supplements, functional foods, and beverages. Manufacturers are focusing on producing clean-label, allergen-free, and sustainably sourced proteins that meet GMP standards. This trend offers growth prospects for companies to develop innovative, high-quality protein ingredients that align with regulatory requirements and consumer preferences, thereby capturing a larger share of the health-focused market segment.
  • Technological Innovations in Protein Manufacturing: Advances in bioprocessing, fermentation, and purification technologies are enabling more efficient, scalable, and cost-effective GMP protein production. These innovations reduce lead times, improve product consistency, and lower costs, making GMP proteins more accessible across various applications. Companies investing in cutting-edge manufacturing techniques can differentiate themselves by offering superior quality products, expanding their market reach, and meeting the increasing global demand for GMP-compliant proteins.
  • Rising Adoption in Clinical Research and Diagnostics: GMP proteins are essential in clinical trials, diagnostics, and laboratory research due to their high purity and consistency. The growing number of clinical studies and diagnostic applications necessitates reliable GMP-grade proteins, creating opportunities for suppliers to expand their product portfolios. This segment offers long-term growth potential as the demand for standardized, high-quality proteins in medical research and diagnostic testing continues to rise globally.
  • Increasing Focus on Sustainable and Ethical Sourcing: Consumers and regulators are emphasizing sustainability, animal welfare, and ethical sourcing in protein production. Companies adopting eco-friendly practices and transparent supply chains can gain competitive advantage. Developing plant-based, insect-derived, or lab-grown GMP proteins aligns with these trends, opening new markets and customer segments. This focus on sustainability enhances brand reputation and compliance, positioning companies to capitalize on the growing demand for ethically produced, high-quality GMP proteins.

These strategic growth opportunities are poised to significantly influence the GMP protein market by fostering innovation, expanding application areas, and meeting evolving regulatory and consumer demands. Companies that leverage technological advancements, prioritize sustainability, and diversify their product offerings will be well-positioned to capture market share and drive long-term growth in this dynamic industry.

GMP Protein Market Driver and Challenges

The GMP protein market is influenced by a variety of technological, economic, and regulatory factors that shape its growth trajectory. Advances in biotechnology and manufacturing processes have enabled higher quality and more cost-effective production of GMP proteins. Economic factors such as increasing healthcare expenditure and rising demand for biopharmaceuticals drive market expansion. Regulatory frameworks ensure safety and efficacy, fostering trust and facilitating market entry. However, challenges like stringent regulations, high R&D costs, and supply chain complexities pose hurdles. Understanding these drivers and challenges is essential for stakeholders to navigate the evolving landscape and capitalize on emerging opportunities within the GMP protein market.

The factors responsible for driving the GMP protein market include:

  • Technological Innovation: The development of advanced bioprocessing techniques, such as recombinant DNA technology and monoclonal antibody production, has significantly enhanced GMP protein manufacturing. These innovations improve yield, purity, and scalability, reducing production costs and enabling faster market entry. As technology continues to evolve, companies can develop more complex biologics, expanding the product pipeline. This technological progress not only boosts efficiency but also ensures compliance with stringent quality standards, fostering confidence among healthcare providers and regulators. Consequently, technological innovation remains a key driver propelling the GMP protein market forward.
  • Rising Demand for Biopharmaceuticals: The global increase in chronic diseases, cancer, and rare disorders has led to a surge in demand for biopharmaceuticals, many of which are GMP-grade proteins. These biologics offer targeted therapies with improved efficacy and fewer side effects, making them preferred choices over traditional drugs. The expanding aging population and rising healthcare awareness further amplify this demand. As pharmaceutical companies seek to meet this growing need, the demand for GMP proteins escalates, fueling market growth. This trend underscores the importance of GMP manufacturing standards in ensuring the safety and effectiveness of these vital therapeutics.
  • Regulatory Frameworks and Standards: Stringent regulatory requirements established by agencies such as the FDA, EMA, and ICH ensure the safety, efficacy, and quality of GMP proteins. These regulations promote high manufacturing standards, fostering trust among healthcare providers and patients. Compliance with these standards often necessitates significant investment in quality control, validation, and documentation processes, which can be challenging for smaller firms. However, adherence to regulatory frameworks also creates barriers to entry, reducing market competition and encouraging innovation among established players. Overall, robust regulatory standards are pivotal in maintaining market integrity and driving continuous improvement in GMP protein production.
  • Strategic Collaborations and Partnerships: Collaborations between biotech firms, pharmaceutical companies, and contract manufacturing organizations (CMOs) are instrumental in expanding GMP protein production capabilities. These partnerships facilitate technology transfer, resource sharing, and risk mitigation, enabling faster development and commercialization of biologics. They also help companies access new markets and diversify their product portfolios. Strategic alliances often lead to cost efficiencies and enhanced expertise, which are crucial in a highly regulated and capital-intensive industry. As collaboration becomes more prevalent, it accelerates innovation and market penetration, making it a significant driver in the GMP protein landscape.
  • Growing Investment in R&D: Increased investment in research and development by pharmaceutical and biotech companies is vital for discovering novel GMP proteins and improving existing manufacturing processes. R&D funding supports the development of innovative biologics, enhances process efficiencies, and ensures compliance with evolving regulatory standards. This investment also helps in overcoming technical challenges associated with large-scale GMP protein production. As R&D activities expand, they lead to a broader pipeline of therapeutics, fostering market growth and competitiveness. The focus on innovation and quality improvement through R&D is thus a critical driver shaping the future of the GMP protein market.

The challenges facing this GMP protein market include:

  • Stringent Regulatory Compliance: Navigating complex regulatory landscapes remains a significant challenge for GMP protein manufacturers. Compliance requires extensive documentation, validation, and quality assurance processes, which are time-consuming and costly. Variations in regulations across regions can complicate global market entry and increase operational complexity. Failure to meet regulatory standards can result in product recalls, delays, or bans, impacting profitability and reputation. As regulations continue to evolve, companies must invest heavily in compliance infrastructure, which can be a barrier for smaller firms and hinder market expansion.
  • High R&D and Manufacturing Costs: Developing GMP-grade proteins involves substantial investment in research, development, and manufacturing infrastructure. The costs associated with process development, validation, quality control, and regulatory approval are significant. These high costs can limit entry for smaller companies and slow down innovation. Additionally, maintaining GMP compliance requires ongoing expenses related to facility upgrades, staff training, and quality assurance. The financial burden can impact profitability and deter investment, posing a persistent challenge to sustainable growth in the GMP protein market.
  • Supply Chain Complexities: Ensuring a reliable supply chain for raw materials, reagents, and consumables is critical for GMP protein manufacturing. Disruptions due to geopolitical issues, pandemics, or logistical challenges can lead to delays and increased costs. The need for cold chain logistics and strict storage conditions further complicates supply chain management. Any interruption can compromise product quality and availability, affecting market supply and trust. Managing these complexities requires significant planning, investment, and risk mitigation strategies, which can be challenging for manufacturers operating in a highly regulated environment.

In summary, the GMP protein market is driven by technological advancements, increasing demand for biologics, regulatory standards, strategic collaborations, and R&D investments. However, it faces challenges such as regulatory compliance, high costs, and supply chain issues. These factors collectively influence market dynamics, with growth prospects hinging on how effectively companies can leverage drivers while overcoming challenges. The markets future will depend on innovation, strategic partnerships, and adaptive regulatory strategies, shaping a competitive and evolving landscape.

List of GMP Protein Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies GMP protein companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the GMP protein companies profiled in this report include-

  • R&D Systems
  • PeproTech
  • GenScript
  • Waisman Biomanufacturing
  • Thermo Fisher Scientific
  • RayBiotech
  • Sino Biological
  • Leadgene Biomedical
  • Bio-Techne
  • ACROBiosystems

GMP Protein Market by Segment

The study includes a forecast for the global GMP protein market by type, application, and region.

GMP Protein Market by Type [Value from 2019 to 2035]:

  • Cytokines
  • Others

GMP Protein Market by Application [Value from 2019 to 2035]:

  • Biopharmaceutical
  • Others

GMP Protein Market by Region [Value from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the GMP Protein Market

The GMP protein market has experienced significant growth driven by increasing demand for high-quality proteins in pharmaceuticals, biotechnology, and food industries. Advances in manufacturing processes, regulatory standards, and technological innovations have shaped the landscape across major economies. Countries are investing in research and development to enhance product quality, ensure compliance, and meet rising consumer and industry needs. The markets evolution reflects a focus on sustainability, cost-efficiency, and expanding applications, making it a critical component of global health and nutrition strategies. Here is a country-specific overview of recent developments in this dynamic market.

  • United States: The US has seen substantial investments in biopharmaceutical manufacturing, with regulatory agencies like the FDA tightening GMP standards to ensure safety and efficacy. Innovations in bioprocessing technologies, such as continuous manufacturing, have improved efficiency. The rise of contract manufacturing organizations (CMOs) has also expanded capacity, supporting the growing demand for GMP-compliant proteins in personalized medicine and vaccines. Additionally, increased funding for biotech startups has accelerated product development and market entry.
  • China: China is rapidly advancing its GMP protein manufacturing capabilities, driven by government initiatives to become a global biotech hub. The country has expanded its GMP-certified facilities and adopted international standards to attract foreign investment. Local companies are focusing on cost-effective production methods and scaling up to meet domestic and export demands. Regulatory reforms have streamlined approval processes, fostering innovation in therapeutic proteins and biosimilars. Collaborations with global firms are also boosting technological transfer and quality improvements.
  • Germany: Germany remains a leader in GMP protein production within Europe, emphasizing high-quality standards and innovation. The country has invested in state-of-the-art manufacturing plants and advanced bioprocessing technologies. German firms are focusing on developing biosimilars and novel biologics, supported by strong regulatory frameworks and research institutions. Sustainability practices, such as reducing waste and energy consumption, are increasingly integrated into manufacturing processes. The country's strategic position facilitates exports across Europe and beyond.
  • India: India is experiencing rapid growth in GMP protein manufacturing, driven by a large domestic market and export opportunities. The industry benefits from a skilled workforce and cost-effective production, enabling competitive pricing. Recent regulatory reforms have improved GMP compliance and quality standards. Indian companies are investing in advanced bioprocessing equipment and R&D to develop biosimilars and innovative therapeutics. The government's focus on healthcare infrastructure and biotech parks further supports industry expansion and global integration.
  • Japan: Japan continues to prioritize high-quality GMP protein manufacturing, with a focus on innovative biologics and regenerative medicines. The country has adopted stringent GMP standards aligned with international regulations, ensuring product safety and efficacy. Japanese firms are investing in cutting-edge technologies like cell culture and gene editing to enhance production capabilities. Collaborations with global biotech companies and academic institutions foster innovation. The government's support for biotech startups and research initiatives sustains Japan's competitive edge in the global GMP protein market.

Features of the Global GMP Protein Market

  • Market Size Estimates: GMP protein market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
  • Segmentation Analysis: GMP protein market size by type, application, and region in terms of value ($B).
  • Regional Analysis: GMP protein market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the GMP protein market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the GMP protein market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the GMP protein market by type (cytokines and others), application (biopharmaceutical and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global GMP Protein Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Cytokines : Trends and Forecast (2019-2035)
  • 4.4 Others : Trends and Forecast (2019-2035)

5. Global GMP Protein Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Biopharmaceutical : Trends and Forecast (2019-2035)
  • 5.4 Others : Trends and Forecast (2019-2035)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global GMP Protein Market by Region

7. North American GMP Protein Market

  • 7.1 Overview
  • 7.2 North American GMP Protein Market by Type
  • 7.3 North American GMP Protein Market by Application
  • 7.4 The United States GMP Protein Market
  • 7.5 Canadian GMP Protein Market
  • 7.6 Mexican GMP Protein Market

8. European GMP Protein Market

  • 8.1 Overview
  • 8.2 European GMP Protein Market by Type
  • 8.3 European GMP Protein Market by Application
  • 8.4 German GMP Protein Market
  • 8.5 French GMP Protein Market
  • 8.6 Italian GMP Protein Market
  • 8.7 Spanish GMP Protein Market
  • 8.8 The United Kingdom GMP Protein Market

9. APAC GMP Protein Market

  • 9.1 Overview
  • 9.2 APAC GMP Protein Market by Type
  • 9.3 APAC GMP Protein Market by Application
  • 9.4 Chinese GMP Protein Market
  • 9.5 Indian GMP Protein Market
  • 9.6 Japanese GMP Protein Market
  • 9.7 South Korean GMP Protein Market
  • 9.8 Indonesian GMP Protein Market

10. ROW GMP Protein Market

  • 10.1 Overview
  • 10.2 ROW GMP Protein Market by Type
  • 10.3 ROW GMP Protein Market by Application
  • 10.4 Middle Eastern GMP Protein Market
  • 10.5 South American GMP Protein Market
  • 10.6 African GMP Protein Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunity by Type
    • 12.2.2 Growth Opportunity by Application
  • 12.3 Emerging Trends in the Global GMP Protein Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis Overview
  • 13.2 R&D Systems
    • Company Overview
    • GMP Protein Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 PeproTech
    • Company Overview
    • GMP Protein Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 GenScript
    • Company Overview
    • GMP Protein Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Waisman Biomanufacturing
    • Company Overview
    • GMP Protein Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Thermo Fisher Scientific
    • Company Overview
    • GMP Protein Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 RayBiotech
    • Company Overview
    • GMP Protein Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Sino Biological
    • Company Overview
    • GMP Protein Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Leadgene Biomedical
    • Company Overview
    • GMP Protein Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Bio-Techne
    • Company Overview
    • GMP Protein Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 ACROBiosystems
    • Company Overview
    • GMP Protein Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global GMP Protein Market
  • Figure 2.1: Usage of GMP Protein Market
  • Figure 2.2: Classification of the Global GMP Protein Market
  • Figure 2.3: Supply Chain of the Global GMP Protein Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the GMP Protein Market
  • Figure 4.1: Global GMP Protein Market by Type in 2019, 2025, and 2035
  • Figure 4.2: Trends of the Global GMP Protein Market ($B) by Type
  • Figure 4.3: Forecast for the Global GMP Protein Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Cytokines in the Global GMP Protein Market (2019-2035)
  • Figure 4.5: Trends and Forecast for Others in the Global GMP Protein Market (2019-2035)
  • Figure 5.1: Global GMP Protein Market by Application in 2019, 2025, and 2035
  • Figure 5.2: Trends of the Global GMP Protein Market ($B) by Application
  • Figure 5.3: Forecast for the Global GMP Protein Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Biopharmaceutical in the Global GMP Protein Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Others in the Global GMP Protein Market (2019-2035)
  • Figure 6.1: Trends of the Global GMP Protein Market ($B) by Region (2019-2025)
  • Figure 6.2: Forecast for the Global GMP Protein Market ($B) by Region (2026-2035)
  • Figure 7.1: Trends and Forecast for the North American GMP Protein Market (2019-2035)
  • Figure 7.2: North American GMP Protein Market by Type in 2019, 2025, and 2035
  • Figure 7.3: Trends of the North American GMP Protein Market ($B) by Type (2019-2025)
  • Figure 7.4: Forecast for the North American GMP Protein Market ($B) by Type (2026-2035)
  • Figure 7.5: North American GMP Protein Market by Application in 2019, 2025, and 2035
  • Figure 7.6: Trends of the North American GMP Protein Market ($B) by Application (2019-2025)
  • Figure 7.7: Forecast for the North American GMP Protein Market ($B) by Application (2026-2035)
  • Figure 7.8: Trends and Forecast for the United States GMP Protein Market ($B) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Mexican GMP Protein Market ($B) (2019-2035)
  • Figure 7.10: Trends and Forecast for the Canadian GMP Protein Market ($B) (2019-2035)
  • Figure 8.1: Trends and Forecast for the European GMP Protein Market (2019-2035)
  • Figure 8.2: European GMP Protein Market by Type in 2019, 2025, and 2035
  • Figure 8.3: Trends of the European GMP Protein Market ($B) by Type (2019-2025)
  • Figure 8.4: Forecast for the European GMP Protein Market ($B) by Type (2026-2035)
  • Figure 8.5: European GMP Protein Market by Application in 2019, 2025, and 2035
  • Figure 8.6: Trends of the European GMP Protein Market ($B) by Application (2019-2025)
  • Figure 8.7: Forecast for the European GMP Protein Market ($B) by Application (2026-2035)
  • Figure 8.8: Trends and Forecast for the German GMP Protein Market ($B) (2019-2035)
  • Figure 8.9: Trends and Forecast for the French GMP Protein Market ($B) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Spanish GMP Protein Market ($B) (2019-2035)
  • Figure 8.11: Trends and Forecast for the Italian GMP Protein Market ($B) (2019-2035)
  • Figure 8.12: Trends and Forecast for the United Kingdom GMP Protein Market ($B) (2019-2035)
  • Figure 9.1: Trends and Forecast for the APAC GMP Protein Market (2019-2035)
  • Figure 9.2: APAC GMP Protein Market by Type in 2019, 2025, and 2035
  • Figure 9.3: Trends of the APAC GMP Protein Market ($B) by Type (2019-2025)
  • Figure 9.4: Forecast for the APAC GMP Protein Market ($B) by Type (2026-2035)
  • Figure 9.5: APAC GMP Protein Market by Application in 2019, 2025, and 2035
  • Figure 9.6: Trends of the APAC GMP Protein Market ($B) by Application (2019-2025)
  • Figure 9.7: Forecast for the APAC GMP Protein Market ($B) by Application (2026-2035)
  • Figure 9.8: Trends and Forecast for the Japanese GMP Protein Market ($B) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Indian GMP Protein Market ($B) (2019-2035)
  • Figure 9.10: Trends and Forecast for the Chinese GMP Protein Market ($B) (2019-2035)
  • Figure 9.11: Trends and Forecast for the South Korean GMP Protein Market ($B) (2019-2035)
  • Figure 9.12: Trends and Forecast for the Indonesian GMP Protein Market ($B) (2019-2035)
  • Figure 10.1: Trends and Forecast for the ROW GMP Protein Market (2019-2035)
  • Figure 10.2: ROW GMP Protein Market by Type in 2019, 2025, and 2035
  • Figure 10.3: Trends of the ROW GMP Protein Market ($B) by Type (2019-2025)
  • Figure 10.4: Forecast for the ROW GMP Protein Market ($B) by Type (2026-2035)
  • Figure 10.5: ROW GMP Protein Market by Application in 2019, 2025, and 2035
  • Figure 10.6: Trends of the ROW GMP Protein Market ($B) by Application (2019-2025)
  • Figure 10.7: Forecast for the ROW GMP Protein Market ($B) by Application (2026-2035)
  • Figure 10.8: Trends and Forecast for the Middle Eastern GMP Protein Market ($B) (2019-2035)
  • Figure 10.9: Trends and Forecast for the South American GMP Protein Market ($B) (2019-2035)
  • Figure 10.10: Trends and Forecast for the African GMP Protein Market ($B) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global GMP Protein Market
  • Figure 11.2: Market Share (%) of Top Players in the Global GMP Protein Market (2025)
  • Figure 12.1: Growth Opportunities for the Global GMP Protein Market by Type
  • Figure 12.2: Growth Opportunities for the Global GMP Protein Market by Application
  • Figure 12.3: Growth Opportunities for the Global GMP Protein Market by Region
  • Figure 12.4: Emerging Trends in the Global GMP Protein Market

List of Tables

  • Table 1.1: Growth Rate (%, 2024-2025) and CAGR (%, 2026-2035) of the GMP Protein Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the GMP Protein Market by Region
  • Table 1.3: Global GMP Protein Market Parameters and Attributes
  • Table 3.1: Trends of the Global GMP Protein Market (2019-2025)
  • Table 3.2: Forecast for the Global GMP Protein Market (2026-2035)
  • Table 4.1: Attractiveness Analysis for the Global GMP Protein Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global GMP Protein Market (2019-2025)
  • Table 4.3: Market Size and CAGR of Various Type in the Global GMP Protein Market (2026-2035)
  • Table 4.4: Trends of Cytokines in the Global GMP Protein Market (2019-2025)
  • Table 4.5: Forecast for Cytokines in the Global GMP Protein Market (2026-2035)
  • Table 4.6: Trends of Others in the Global GMP Protein Market (2019-2025)
  • Table 4.7: Forecast for Others in the Global GMP Protein Market (2026-2035)
  • Table 5.1: Attractiveness Analysis for the Global GMP Protein Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global GMP Protein Market (2019-2025)
  • Table 5.3: Market Size and CAGR of Various Application in the Global GMP Protein Market (2026-2035)
  • Table 5.4: Trends of Biopharmaceutical in the Global GMP Protein Market (2019-2025)
  • Table 5.5: Forecast for Biopharmaceutical in the Global GMP Protein Market (2026-2035)
  • Table 5.6: Trends of Others in the Global GMP Protein Market (2019-2025)
  • Table 5.7: Forecast for Others in the Global GMP Protein Market (2026-2035)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global GMP Protein Market (2019-2025)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global GMP Protein Market (2026-2035)
  • Table 7.1: Trends of the North American GMP Protein Market (2019-2025)
  • Table 7.2: Forecast for the North American GMP Protein Market (2026-2035)
  • Table 7.3: Market Size and CAGR of Various Type in the North American GMP Protein Market (2019-2025)
  • Table 7.4: Market Size and CAGR of Various Type in the North American GMP Protein Market (2026-2035)
  • Table 7.5: Market Size and CAGR of Various Application in the North American GMP Protein Market (2019-2025)
  • Table 7.6: Market Size and CAGR of Various Application in the North American GMP Protein Market (2026-2035)
  • Table 7.7: Trends and Forecast for the United States GMP Protein Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican GMP Protein Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian GMP Protein Market (2019-2035)
  • Table 8.1: Trends of the European GMP Protein Market (2019-2025)
  • Table 8.2: Forecast for the European GMP Protein Market (2026-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the European GMP Protein Market (2019-2025)
  • Table 8.4: Market Size and CAGR of Various Type in the European GMP Protein Market (2026-2035)
  • Table 8.5: Market Size and CAGR of Various Application in the European GMP Protein Market (2019-2025)
  • Table 8.6: Market Size and CAGR of Various Application in the European GMP Protein Market (2026-2035)
  • Table 8.7: Trends and Forecast for the German GMP Protein Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French GMP Protein Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish GMP Protein Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian GMP Protein Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom GMP Protein Market (2019-2035)
  • Table 9.1: Trends of the APAC GMP Protein Market (2019-2025)
  • Table 9.2: Forecast for the APAC GMP Protein Market (2026-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC GMP Protein Market (2019-2025)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC GMP Protein Market (2026-2035)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC GMP Protein Market (2019-2025)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC GMP Protein Market (2026-2035)
  • Table 9.7: Trends and Forecast for the Japanese GMP Protein Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian GMP Protein Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese GMP Protein Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean GMP Protein Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian GMP Protein Market (2019-2035)
  • Table 10.1: Trends of the ROW GMP Protein Market (2019-2025)
  • Table 10.2: Forecast for the ROW GMP Protein Market (2026-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW GMP Protein Market (2019-2025)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW GMP Protein Market (2026-2035)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW GMP Protein Market (2019-2025)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW GMP Protein Market (2026-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern GMP Protein Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American GMP Protein Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African GMP Protein Market (2019-2035)
  • Table 11.1: Product Mapping of GMP Protein Suppliers Based on Segments
  • Table 11.2: Operational Integration of GMP Protein Manufacturers
  • Table 11.3: Rankings of Suppliers Based on GMP Protein Revenue
  • Table 12.1: New Product Launches by Major GMP Protein Producers (2019-2025)
  • Table 12.2: Certification Acquired by Major Competitor in the Global GMP Protein Market